The U.S. Food and Drug Administration (FDA), an agency within the Department of Health and Human Services, supports the principle of openly sharing data through efforts like the Patient Safety Movement Foundation’s Open Data Pledge. Creating a healthcare system that embraces data liquidity will help empower patients to actively engage in the development and evaluation of medical devices, enable medical device surveillance to help identify and prevent adverse events from occurring, and enrich the understanding of the benefits and risks of technology utilization.
By signing the Patient Safety Movement’s Open Data Pledge, leaders in the healthcare technology industry commit to openly sharing non-proprietary data output from their devices and systems without interference or cost. When the data is pulled together into algorithms, it can then be used to reduce preventable patient harm and deaths.
“We are grateful for FDA’s recognition of our work and thank the nearly 100 enlightened companies that have signed the Open Data Pledge. Patient harm can be avoided with predictive algorithms and decision support using data from the myriad of products that touch the patient,” stated Joe Kiani, Founder of Patient Safety Movement Foundation.
Click here to view the letter of support